Fatty liver and the metabolic syndrome among Shanghai adults. - Wikidata - awgldk - TriplyDB

Fatty liver and the metabolic syndrome among Shanghai adults.

Fatty liver and the metabolic syndrome among Shanghai adults.

http://www.wikidata.org/entity/Q46841528

about

Non-alcoholic fatty liver disease: what the clinician needs to know.Nonalcoholic Fatty liver disease and risk of diabetes and cardiovascular disease: what is important for primary care physicians?Diagnosis and management of non-alcoholic fatty liver disease and related metabolic disorders: consensus statement from the Study Group of Liver and Metabolism, Chinese Society of Endocrinology Obesity and non-alcoholic fatty liver disease: Disparate associations among Asian populations Cancer prevention and control: alarming challenges in China Epidemiology of alcoholic and nonalcoholic fatty liver disease in China.What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?Prediction of metabolic syndrome by non-alcoholic fatty liver disease in northern urban Han Chinese population: a prospective cohort study.Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits.The C-681G polymorphism of the PPAR-γ gene is associated with susceptibility to non-alcoholic fatty liver disease.Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database.Sonographic fatty liver and hepatitis B virus carrier status: synergistic effect on liver damage in Taiwanese adults Prevalence of fatty liver disease and its risk factors in the population of South China.Pathogenesis and therapeutic approaches for non-alcoholic fatty liver disease Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease.Evaluation of abdominal ultrasonography mass screening for hepatocellular carcinoma in Taiwan Gender differences in the prevalence and development of metabolic syndrome in Chinese population with abdominal obesity The effect of miRNA-122 in regulating fat deposition in a cell line model.Mechanisms and implications of age-related changes in the liver: nonalcoholic Fatty liver disease in the elderly.Association of serum alanine aminotransferase and γ-glutamyltransferase levels within the reference range with metabolic syndrome and nonalcoholic fatty liver disease.Development and validation of a simple index system to predict nonalcoholic fatty liver disease Prevalence of Non-Alcoholic Fatty Liver Disease and Its Predictors in North of Iran.Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome Serum N(1)-Methylnicotinamide Is Associated With Obesity and Diabetes in Chinese.Effect of nonalcoholic Fatty liver disease on the development of type 2 diabetes in nonobese, nondiabetic korean men.Identification of reciprocal causality between non-alcoholic fatty liver disease and metabolic syndrome by a simplified Bayesian network in a Chinese population The Prevalence of Nonalcoholic Fatty Liver Disease and Related Metabolic Comorbidities Was Associated with Age at Onset of Moderate to Severe Plaque Psoriasis: A Cross-Sectional Study.Apolipoprotein A-I modulates processes associated with diet-induced nonalcoholic fatty liver disease in mice Clinical spectrum of non-alcoholic fatty liver disease in diabetic and non-diabetic patients.An exploration of prevalence and associated factors of nonalcoholic Fatty liver disease in the taiwanese police service.An update on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Asia.Genetic and epigenetic variants influencing the development of nonalcoholic fatty liver disease.Nonalcoholic fatty liver disease and cardiovascular disease: has the time come for cardiologists to be hepatologists?Metabolic Syndrome and Risk of Cervical Human Papillomavirus Incident and Persistent Infection.Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: An 8-year follow-up study How should we manage patients with non-alcoholic fatty liver disease in 2007?The global burden of liver disease: the major impact of China Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.Association between metabolic syndrome and the development of non-alcoholic fatty liver disease

P2860

Q24563068-0DA466B3-4E03-412B-BC7E-B05B94837885 Q26827169-C1B4D9B0-AF21-46EF-B246-431676AA9555 Q26998471-3ABF0792-1A57-43D5-A4E7-291E2FEE9C58 Q28386598-91A1FFAC-872E-4832-9B86-1DC7723F8634 Q28396786-8280E848-40FB-477F-A249-F631B1D00519 Q30352093-3DF84A2E-D006-4B64-B61B-1BA8B3EAA291 Q30361645-90F25A54-5E54-4E13-8AA0-6D80752AF1B6 Q33573424-D8F2F05C-D080-458C-A8A9-3D3593538E78 Q33851563-84ED839D-B9BC-459A-9182-14FF88A62A97 Q34019843-383B0428-B565-4612-A21F-BEFBCD1D688D Q34077811-CEAD396D-61FF-46F4-8DBB-9875368FC5F9 Q34112196-F78ED6A8-6859-42BD-A424-430120264306 Q34382961-4E5A4EEC-0D1A-4A53-B888-5B24072F5FFD Q34449857-8F421E12-72AE-4678-80B8-E65CCA15E7B1 Q34501554-7ED88080-4AD0-47FD-8BD1-384A5C2E11BB Q34759018-1BA852CC-6B75-4529-94A3-B9808DC57192 Q34974963-5B049375-C0D1-406F-8CA1-EC636C6A90CF Q35032518-2F583A24-7C91-45FC-8C0B-3CAB48295D1F Q35056293-987F815F-1ADD-4E4B-92D4-863F5755876B Q35209849-C540BA59-4288-49A7-A111-444B64F0ADEF Q35833048-19D70468-2B7F-46FD-A607-0DB9E847B4B5 Q35833053-B7B9D72A-809D-42C4-B578-AD5636E48D55 Q35846367-E0D0E0E3-EE73-43C0-B638-070D6BB8D356 Q35872059-FB4F1F60-E4BA-4737-B5D3-8E142D393BFF Q35916575-E7FDC9F6-D68B-4777-ACEA-AFADDC76C6A1 Q36113307-AF40E195-76EC-4E58-91E2-5F6C3D99D9CC Q36120514-BE016119-D654-4F59-AEA1-64CDE9D5E4CF Q36252677-7DB414E5-8425-4FA1-9980-E1A139D3EC02 Q36283410-1738555A-71BB-46ED-B69A-E54505B38FD4 Q36323714-BDD3F0D1-75FE-4770-A234-1E038A00319A Q36349054-AA81E20E-5EB5-4F05-8E3E-9916ED945A56 Q36405031-0A256FB5-8C74-4B74-A8D0-A102641F51BB Q36450465-CE1D946B-A893-4739-B81E-26C68582CAE9 Q36520139-E4EA5805-6BBE-404C-8E5A-09FDC9AE96D1 Q36663953-070F20FB-9589-48A8-BD43-040A43986CFA Q36747541-EB637E23-910E-453A-93EF-939074A350CB Q36848280-6B5B5D36-B673-4D73-A085-4793E6D66279 Q36901892-B7BFBB29-E593-49C8-97EF-9EC2E0A45E45 Q36953626-75B8F03C-15BB-4179-BAAE-8662351F5145 Q37075582-1DFF4525-36D6-401C-87BC-84A71A62DD7F

P2860

Fatty liver and the metabolic syndrome among Shanghai adults.

http://www.wikidata.org/entity/Q46841528

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Fatty liver and the metabolic syndrome among Shanghai adults.

@en

Fatty liver and the metabolic syndrome among Shanghai adults.

@nl

type

label

Fatty liver and the metabolic syndrome among Shanghai adults.

@en

Fatty liver and the metabolic syndrome among Shanghai adults.

@nl

prefLabel

Fatty liver and the metabolic syndrome among Shanghai adults.

@en

Fatty liver and the metabolic syndrome among Shanghai adults.

@nl

P1433

Q46841528-F4F8DD58-0CD1-4EAB-B036-17F7DDC2E488

P1476

Q46841528-09D83585-6FAF-4FFE-A36A-9A09991A4E32

P2093

Q46841528-4EAFE7DD-47BA-43E2-ACD9-8E3F713D16F1

Q46841528-7654CF21-ED26-4BFB-B981-8035CBDD51C9

Q46841528-9B6D1538-7FDC-4D09-9861-81C8CF66D73C

Q46841528-AF541D9D-3B70-48FA-93A9-594B76CBC013

Q46841528-B7D92304-3163-411A-8E7A-A175733A01D2

Q46841528-BB76B043-C29E-49A1-977E-40515F8FB775

Q46841528-CBA49854-577B-4812-99D6-1913F8C60F1B

Q46841528-D3170EC3-F06E-4ECF-9DD1-7C7AD5AB24D7

Q46841528-DDE1926A-08A3-4C83-B7FC-E6518D6C4E24

P2860

Q46841528-358DDCE7-0CEB-49A6-B9F4-F02972DB7E3C

Q46841528-37DD9022-53E1-40EC-AF18-F4345504B042

Q46841528-451F0C95-2717-4E9B-AA02-D271E98EADC9

Q46841528-485187C5-FB6D-4F45-BB56-372F14FDF540

Q46841528-4DEA250B-B865-401B-A5D5-10455846E26F

Q46841528-61AD485A-31AA-4D30-B6B7-D4590DEDA4C3

Q46841528-653B0AC5-7643-49A6-934D-F08813AA413E

Q46841528-95C2A258-E6F5-4373-8020-5BF8EC038871

Q46841528-A5539E04-FDCF-474E-8EFB-3DC31EDA06A9

Q46841528-AB5FEA4B-6191-4CF6-8D34-B1A378A419B2

P304

Q46841528-4C62EC21-82D2-43C7-BD61-98CF32A35221

P31

Q46841528-60AEB096-08D6-4DC9-A8DD-0D516B73DD6F

P356

Q46841528-77DD332B-A585-4ECF-A1AE-4FA4176E3FC7

P433

Q46841528-7E00E166-B296-48C7-8C21-26DCAE7EC434

P478

Q46841528-2200765E-96FB-4D6C-BF65-D3A7D0798C21

P577

Q46841528-E77D9F2F-4544-4D55-B8EE-284A9460C30D

P698

Q46841528-7FA16A0F-A4F7-4E60-BFB1-98328E2E13E1

P921

Q46841528-0B8A0288-40B4-45E2-A624-6A195D15461D

P356

J.1440-1746.2005.04058.X

P1433

Journal of Gastroenterology and Hepatology

P1476

Fatty liver and the metabolic syndrome among Shanghai adults.

@en

P2093

Fei Dai

http://www.w3.org/2001/XMLSchema#string

Feng Li

http://www.w3.org/2001/XMLSchema#string

Jian-Gao Fan

http://www.w3.org/2001/XMLSchema#string

June Zhu

http://www.w3.org/2001/XMLSchema#string

Lan Chen

http://www.w3.org/2001/XMLSchema#string

Lui Li

http://www.w3.org/2001/XMLSchema#string

Shi-Yao Chen

http://www.w3.org/2001/XMLSchema#string

Xing-Jian Li

http://www.w3.org/2001/XMLSchema#string

Yuan-San Lu

http://www.w3.org/2001/XMLSchema#string

P2860

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

The new BMI criteria for asians by the regional office for the western pacific region of WHO are suitable for screening of overweight to prevent metabolic syndrome in elder Japanese workers.

The spectrum of liver disease in the general population: lesson from the Dionysos study.

Elevated body fat percentage and cardiovascular risks at low body mass index levels among Singaporean Chinese, Malays and Indians.

AGA technical review on nonalcoholic fatty liver disease.

Prevalence of the metabolic syndrome among 40,698 Korean metropolitan subjects.

Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease.

Defining nonalcoholic fatty liver disease: implications for epidemiologic studies.

P304

1825-1832

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1440-1746.2005.04058.X

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2005-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16336439

http://www.w3.org/2001/XMLSchema#string

P921

metabolic syndrome